                               NIH Public Access
                               Author Manuscript
                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                           Published final edited form 
NIH-PA Author Manuscript




                            J Neurosci. 2012 September 5; 32(36): 12630–12640. doi:10.1523/JNEUROSCI.0277-12.2012.



                           Integration β-catenin, Sirtuin FOXO Signaling Protects
                           Mutant Huntingtin Toxicity
                           J. Alex Parker1,2,†,#, Rafael Vazquez-Manrique1,2,#, Cendrine Tourette1,2,◊, Francesca
                           Farina1,2, Nicolas Offner1,2, Arnab Mukhopadhyay3,‡, Anne-Marie Orfila1,2, Aurélie
                           Darbois1,2, Sophie Menet1,2, Heidi  Tissenbaum3, Christian Neri1,2,4,*
                           1INSERM, Unit 894, Laboratory Neuronal Cell Biology Pathology, 75014 Paris, France

                           2University   Paris Descartes, EA 4059, 75014 Paris, France
                           3Programin Gene Function Expression, Program Molecular Medicine, University                            Massachusetts Medical School, Worcester MA 01605, USA
                           4AP-HP,    Department Neurology, Henri Mondor Hospital, 94000 Créteil, France
NIH-PA Author Manuscript




                           Abstract
                                 current challenges neurodegenerative disease research determine                                  signaling pathways essential cellular homeostasis contribute neuronal survival
                                 modulate pathogenic process human disease. C. elegans, sir-2.1/SIRT1
                                 overexpression protects neurons early phases expanded polyglutamine (polyQ)
                                 toxicity, protection requires lonfity-promoting factor daf-16/FOXO.                                   neuroprotective effect requires DAF-16/FOXO partner bar-1/β-catenin putative
                                 DAF-16 regulated gene, ucp-4, sole mitochondrial uncoupling protein (UCP) nematodes.
                                 results fit previously-proposed mechanism β-catenin, FOXO SIRT1
                                 proteins regulate gene expression cell survival. Knockdown β-catenin
                                 enhanced vulnerability cell death mutant-huntingtin striatal cells derived                                  HdhQ111 knock mice. addition, effect compensated SIRT1 overexpression                                  accompanied modulation neuronal UCP expression levels, highlighting cross-
                                 talk β-catenin SIRT1 modulation mutant polyQ cytoxicity. Taken 
                                 results suggest integration β-catenin, sirtuin FOXO signaling protects                                  early phases mutant huntingtin toxicity.
NIH-PA Author Manuscript




                           Introduction
                                            Huntington’s Disease (HD) dominantly-inherited CAG repeat disorder expanded
                                            polyglutamine (polyQ) tracts huntingtin (htt), causing striatal cortical degeneration
                                            (Walker, 2007). person carrying 39 CAG repeats invariably develop
                                            HD, age onset HD varies considerably. CAG expansions account                                             60  variability age onset HD, residual variability                                             heritable suggesting genes influence age onset (Li et al., 2003; Gayan et al.,
                                            2008; Metzger et al., 2008; Taherzadeh-Fard et al., 2009; Xu et al., 2009). Given HD                                             age-related disorder, candidate gene approaches based longevity modulators 

                           *
                            Correspondence addressed Christian Neri, Inserm Unit 894, 2-ter rue d’Alesia, 75014 Paris, France.
                           christian.neri@inserm.fr.
                           †Current address: CRCHUM, Département pathologie et biologie cellulaire, Université Montréal, Montréal, Canada
                           ◊Current address: Buck Institute, Novato, CA 94945
                           ‡Current address: Molecular Aging Laboratory, National Institute Immunology, New Delhi 110067, India
                            authors contributed equally work.
                            Parker et al.                                                                                             Page 2


                                           examined identify disease modifiers. Studies TCERG1, evolutionary-
                                           conserved transcriptional regulator modulates longevity C. elegans (Ghazi et al.,
                                           2009), showed protein neuroprotective models HD (Arango et al., 2006) NIH-PA Author Manuscript




                                           polymorphic Gln-Ala repeat modifies HD American patients (Holbert et al.,
                                           2001). longevity modulator neuroprotective activities transcription factor
                                           daf-16/FOXO. FOXO proteins essential stress resistance (Brunet et al., 2004),                                            daf-16 required neuroprotection increased dosage sirtuin sir-2.1/SIRT1                                            expanded-polyQ nematodes (Parker et al., 2005). cofactors regulate FOXO activity,
                                           FOXOs targets (Greer Brunet, 2008; Landis Murphy, 2010; Yen et
                                           al., 2011), suggesting network genes centered FOXO regulate mutant
                                           polyglutamine neuron survival role HD variability. Interestingly regard,
                                           FOXO activity conserved C. elegans humans human FOXO3A                                            associated ability long-lived populations centenarians (Willcox et
                                           al., 2008; Anselmi et al., 2009; Li et al., 2009; Soerensen et al., 2010).  investigated
                                           neuroprotective role Wnt effector BAR-1/β-catenin, protein binds                                            DAF-16/FOXO3a regulate transcriptional activity response oxidative stress                                            C. elegans mammalian cells (Essers et al., 2005), ucp-4, sole
                                           mitochondrial uncoupling protein (UCP) C. elegans putative DAF-16 transcriptional
                                           target. end, used C. elegans transgenics expressing exon-1 like htt touch
                                           receptor neurons (Parker et al., 2005). Animals expressing expanded polyQs strong
                                           neuronal dysfunction phenotype (defective response touch) absence cell death
NIH-PA Author Manuscript




                                           (Parker et al., 2005), recapitulating early phase mutant htt neurotoxicity. Additionally,
                                           tested effects SIRT1, β-catenin neuronal UCPs (UCP2, UCP4)                                            survival striatal cells derived htt knock mice (Trettel et al., 2000). detailed
                                            results suggest integration β-catenin, sirtuin FOXO signaling protects
                                           early phases mutant htt toxicity.

                               Materials Methods
                               Nematode experiments
                                           wild-type strain C. elegans used Bristol N2. Standard methods culturing                                            handling worms hermaphrodites males used. strains scored 20°C.
                                           Touch tests, scoring PLM cell processes, drug response assays quantitative Real-
                                           Time PCR performed previously described (Parker et al., 2005). Western analysis
                                           performed using standard protocols htt fusion proteins detected GFP
                                           antibody ab6556 (Abcam). Mutations transgenes used study listed Table 1.
                                           strains obtained C. elegans Genetics Center (University Minnesota,
                                           Minneapolis) generated laboratory. strain construction                                            polyQ transgenes, mutants verified visible phenotypes, PCR analysis deletion
NIH-PA Author Manuscript




                                           mutants, sequencing point mutations combination thereof. Deletion mutants                                            outcrossed minimum times wild-type geIs3[sir-2.1(+)] strain outcrossed
                                           times wild-type prior use. geIs3[sir-2.1(+)] animals tested dye filling
                                           defect previously described (Burnett et al., 2011) showed defect regard.

                                           test rescue effets sir-2.1 LOF 128Q animals, constructs encoding SIR-2.1
                                           generated follows. assembled sir-2.1 cDNA bicistronic GFP
                                           (biGFP) PCR fusion. obtained sir-2.1 cDNA wildtype animals RT-PCR,
                                           using RV197 (5'-
                                           GGGGACAACTTTGTATACAAAAGTTGATGTCACGTGATAGTGGCAAC)                                            RV198 (5′-GTGAAAGTAGGATGAGACAGCTCAGATACGCATTTCTTCAC) primers.
                                           RV198 contains sequence complementary 5' region biGFP. amplified biGFP
                                           pAN51 using RV192 (5′-GCTGTCTCATCCTACTTTCAC) RV178 (5′-
                                           GGGGACCACTTTGTA

                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                           Page 3


                                           CAAGAAAGCTGGGTATTATAGTTCATCCATGCCATGTGTA).  fused                                            PCR products nested PCR using primers RV197 RV178. primers contain
                                           respectively attB5 attB2 sequences recombination pDONR221-P5-P2 vector,
NIH-PA Author Manuscript




                                           using Gateway (Invitrogen). parallel, produced clone, pDONR221-P1-
                                           P5r, containing promoter mec-3, mec-3p, using primers RV3 (5'-
                                           GGGGACAAGTTTGTACAAAAAAGC AGGCTCCTGCAGGTACCCGGAGTAGTTG)
                                           RV4 (5′-GGGGACAACTTTTGTATA
                                           CAAAGTTGTGGCGCGCCAATGCGCGAAATTGTGGCTACTC). clones used
                                           assemble mec-3p sir-2.1-biGFP, using Gateway technology, destination vector
                                           pDEST  suitable C. elegans transgenesis.

                                           test rescue effets bar-1 LOF 128Q animals, constructs encoding BAR-1
                                           generated follows. assembled bar-1 cDNA bicistronic mCherry (bi-
                                           mCherry) PCR fusion. obtained bar-1 cDNA wildtype animals RT-PCR,
                                           using RV229 (5’-GGGGACAACTTTGTATACAAAAGTTGATGGAC
                                           CTGGATCCGAACCTAG) RV230 (5’-
                                           GTGAAAGTAGGATGAGACAGCTTAAAATCGACTATTCCTAGAAG) primers.
                                           RV230 contains sequence complementary 5' region bimCherry. amplified bi-
                                           mCherry pGEM-T-bicistronic-mCherry construct using RV192 (5'-
                                           GCTGTCTCATCCTACTTTCAC) universal primer SP6.  fused PCR
                                           products nested PCR using primers RV229 RV8 (5'-
NIH-PA Author Manuscript




                                           GGGGACCACTTTGTACAAGAAAGCTGGGTATTATTTGTATAGTTCATCCATGCC
                                           ACC). primers contain respectively attB5 attB2 sequences recombination                                            pDONR221-P5-P2 vector, using Gateway (Invitrogen). combined                                            resulting construct plasmid pDONR221-P1-P5r  contains mec-3p)                                            generate bar-1 overexpression construct, means Gateway technology,                                            destination vector pDEST  suitable C. elegans transgenesis.

                                           Constructs mCherry expression control UCP-4 promoter (1768 bp)                                            generated follows. fused promoter UCP-4  position 1768 bp upstream
                                           ATG ucp-4) ucp-4 gene mCherry∷unc-54Terminator. Primers used                                            amplify ucp-4 Forward 5’-TTTTGCGTTTGCTCGTCGCAC Reverse 5’-
                                           AGTCGACCTGCAGGCATGCAAGCT. amplified mCherry plasmid generated
                                           replacing GFP pPD95.75 mCherry using primers Forward 5’-
                                           AGCTTGCATGCCTGCAGGTCGACT Reverse 5’
                                           GGAAACAGTTATGTTTGGTATATTGGG. Constructs encoding mCherry                                            control ucp-4 promoter (1768 bp), wild-type scrambled binding site 2,
                                           generated follows. amplified promoter ucp-4  position 1768 bp
                                           upstream ATG ucp-4) cloned PCR fragments pRV10  derivative NIH-PA Author Manuscript




                                           pPD95.75, GFP substituted mCherry). Primers used amplify                                            ucp-4 promoter sequence Forward 5’-
                                           GGGGAAGCTTTTTTGCGTTTGCTCGTCGCAC Reverse 5’-GGGG
                                           CCCGGGCATCTGAATAAAAGTTATAATTCC. Primers used mutagenize DAF-16
                                           binding site 2 Forward 5’-
                                           AAATACATGTTTGATTCTTTTTGAATACAGCTGTGACGTAA Reverse 5’-
                                           GCTGTATTCAAAAAGAATCAAACATGTATTTAAATACATTTG  scrambled
                                           sequence underligned). constructs verified sequence integrity.

                                           transgenesis, 5–20 ng/µl DNA constructs injected 19Q 128Q
                                           nematodes, pPD118.33  plasmid containing myo-2p∷GFP), final total
                                           DNA concentration 100–150 ng/µl, using standard methods. isolated                                            independent strains construct perform touch tests. Strains stably expressing
                                           UCP-4-mCherry reporter crossed wild-type N2 strain strain


                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                           Page 4


                                           overexpressing translational construct encoding DAF-16∷GFP (TJ356, insertion
                                           zIs356IV) (Henderson Johnson, 2001), animals homozygous allele (wt/wt,
                                           daf-16∷GFP/daf-16∷GFP) isolated. Similar crosses perfomed using strains stably
NIH-PA Author Manuscript




                                           expressing mCherry control ucp-4 promoter carried wild-type                                            scrambled DAF-16 binding site 2. mCherry signals scored blindly using Zeiss
                                           fluorescence microscope (10x) quantification performed using ImageJ.

                                           Touch tests involved scoring response light touch tail using fine hair.
                                           Touch tests performed blindly scoring 10 touches tail young adult
                                           animal minimum 200 animals/genotype (50–60 animals independent experiment
                                           total 4 independent experiments). Touch tests strains expressing
                                           extrachromosomal arrays involved minimum 60 animals/array (20–30 animals                                            independent experiment total 3 independent experiments). Ordinarily, wild-
                                           type animals respond backing away touch. responses recorded                                            animal  example, 3 responses 10 tail given 30 
                                           responsiveness, mean values responsiveness retained comparison                                            nematode groups. nematodes habituated approximately 30 touch
                                           stimuli, restricting analysis 10 touch challenges ensures significant habituation
                                           occurs range (Giles Rankin, 2009). Axonal aggregation axonal swelling
                                           scored previously described (Parker et al., 2005) testing minimum 100
                                           animals treatment. primers used qRT-PCR analysis htt transgene expression
NIH-PA Author Manuscript




                                           Forward 5'-CACTTGTCACTACTTTCTCAT Reverse 5'-
                                           GTAGTTCCCGTCATCTTTG, primers Forward 5'-
                                           CTTCTGCAAGGGATCTGCTAAG Reverse 5'-GATTTGGAGCTGGGTTGACTTC
                                           used amplification housekeeping gene col-1 control. Proteins extracted
                                           animals previously described (Parker et al., 2005), separated SDS-PAGE
                                           analyzed Western blotting using mouse anti-htt (GenScript A00089, 1:500)                                            mouse anti-actin (MP Biomedicals, 1:10,000). Secondary antibodies goat anti-mouse
                                           IgG HRP-conjugated (Biorad). Proteins detected using ECL+ evaluated                                            densitometry using GS-800 densitometer (BIORAD) quantification performed
                                           using ImageJ.

                                           Chromatin immunoprecipitation (ChIP) performed described previously (Oh et al.,
                                           2006; Mukhopadhyay et al., 2008) using DAF-16 antibody generated C-
                                           terminal portion DAF-16a2 (Oh et al., 2006) wild type (N2), daf-2(e1370),
                                           daf-16(mgDf50) daf-16(mgDf50);daf-2(e1370) worms. Binding ChIP samples                                            determined real-time PCR using following primers: binding site 1-
                                           tctgtgtcagcagcttttcg acggccgtccgtaatagata, binding site 2- tgagcaagttgtaatggggtta                                            catctggcacttatggggtta, 3’-region- aaccaggagcaccattcaac gcaacttcttcctgctgacc.
NIH-PA Author Manuscript




                               Mammalian experiments
                                           Cell death assays HdhQ111 mouse striatal cells expressing length htt                                            wild-type (7Q/7Q) mutant (109Q/109Q) polyglutamines performed previously
                                           described, cell death induced 1-day serum deprivation (Arango et al., 2006).                                            used jetPEI transfection cDNA jetSI-ENDO transfection RNA
                                           molecules indicated manufacturer (PolyPlus Transfection). siRNAs (si-htt, si-
                                           β-catenin, si-SIRT1, si-SIRT2, si-SIRT3, si-UCP2, si-UCP4) scramble RNAs                                            obtained QIAGEN. htt siRNAs described (DiFiglia et
                                           al., 2007), mixes 3–4 different siRNA sequences gene (25 33 nM)                                            systematically tested modulation cell survival siRNA target gene expression,
                                           followed evaluation individual siRNA sequences optimal concentration (25–100
                                           nM). Effects cell survival considered reliable 2 different siRNAs showed
                                           similar effects target mRNA/protein expression cell survival scramble RNAs

                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                          Page 5


                                           (25–100 nM) did effect. active siRNA sequences shown figures                                            follows: htt siRNA, 5'-TTCATCAGCTTTTCCAGGGTC (100 nM), β-catenin siRNA, 5’-
                                           GGCTTTTCCCAGTCCTTCATT (100 nM); SIRT1 siRNA, 5’-
NIH-PA Author Manuscript




                                           GATTGTTATTAATATCCTTTT (25 nM); SIRT2 siRNA 5'-
                                           TTGGGTGAAGTTCTATTTGTT (25 nM); SIRT3 siRNA, 5'-
                                           TTACCGATCAACATGCTAGTT (25 nM); UCP2 siRNA, 5’-
                                           GAAGAACGAGACACCTTTA (33 nM), UCP4 siRNA 5'-
                                           CGCCATTTACAGACAGGTA (33 nM). corresponding scramble RNAs                                            follows: htt, 5'-GTCCAGATTTCCCTGTCGTAT (100 nM); β-catenin, 5’-
                                           GCTCTCGCCATATGAATCTCT (100 nM); SIRT1, 5’-GTTTATGCTCATTATATAT (25
                                           nM); SIRT2 5'-GTTAGTTAGTTCGTGTAGT (25 nM); SIRT3, 5’-
                                           GCTATGTATCAGCACACTA (25 nM); UCP2, 5’-GCATAAGACCGACAATAGT (33
                                           nM), UCP4, 5'-GAGCCATCAACTGACTAGT (33 nM). construct encoding                                            active variant SIRT1 (2 kb cDNA) lacking internal segment N-terminus                                            pCDNA3.1-sirt1-Flag. Cells subjected DAPI staining cell death scored 48
                                           hours cell transfection counting picnotic versus normal nuclei DAPI- JetSI-
                                           ENDO-positive cells. Cytoplasmic nuclear proteins extracted previously
                                           described (Arango et al., 2006), separated SDS-PAGE analyzed Western blotting
                                           using following primary antibodies: mouse anti-SIRT1 (Upstate, 1:1000), mouse anti-
                                           SIRT2 (Santa Cruz, 1:100), rabbit anti-SIRT-3 (Abgent, 1:100), rabbit anti-β-catenin (Cell
                                           Signaling, 1:5000), goat anti-UCP2 (Santa Cruz, dilution), rabbit anti-UCP4 (Abcam, 1:25),
NIH-PA Author Manuscript




                                           mouse anti-htt (4C8, Chemicon, 1:5000 GenScript A00089, 1:500), mouse anti-actin
                                           (Invitrogen, 1:2000), rabbit anti-NCAM (Chemicon, 1:10,000). Secondary antibodies                                            goat anti-mouse IgG HRP-conjugated goat anti-rabbit IgG HRP-conjugated (Biorad).
                                           Proteins detected using ECL+ evaluated densitometry using GS-800
                                           densitometer (BIORAD) quantification performed using ImageJ. Chemicals                                            purchased Calbiochem (BIO, LiCl).

                               RNA Isolation qRT-PCR striatal cells
                                           Quantitative RT-PCR performed RNA extracted 109Q/109Q mouse striatal
                                           cells, transfected appropriate siRNAs scramble RNAs, assess gene silencing
                                           efficiency. days cell transfection, RNA extracted Qiagen Rneasy kit
                                           DnaseI (Sigma) treatment  manufacturers protocol). Single strand cDNA
                                           synthesis using oligoDT, random hexamer priming 100ng total RNA                                            Absolute 2-Step QRT-PCR SYBR ROX kit (AbGene). Quantitative PCR performed
                                           using SYBR® Green ABI PRISM® 7700 Sequence Detection (Applied
                                           Biosystems) oligonucleotides follows: ucp2-f (5’-
                                           TCCTGCTACCTCCCAGAAGA), ucp2-r (5’-TGAGACCTCAAAGCAGCCTC), ucp4-f
NIH-PA Author Manuscript




                                           (5’-GTGACGCCCGCCATTTACAG), ucp4-r (5’-CATCCCTCCAATGACCGATTTCC),
                                           sirt2-f (5’-CCCTTCGCCTCCCTCATC), sirt2-r (5’-GTCCCTGTAAGCCTTCTTGG),
                                           sirt3-f (5’-TGGCTGACTTCGCTTTGG), sirt3-r (5’-TCCACACCATGAACTACATCC),
                                           rpl13a-f (5’-CTGCTGCTCTCAAGGTTGTTC), rpl13a-r (5’-
                                           CTGCTTCTTCTTCCGATAGTGC), hprt-f (5’-TTTGCCGCGAGCCG), hprt-r (5’-
                                           TAACCTGGTTCATCATCGCTAATC). Assays data analysis performed
                                           according manufacturer's protocol (User Bulletin #2, ABI PRISM® 7700 Sequence
                                           Detection  Perkin Elmer). samples run triplicate using rpl13a                                            hprt calibrator gene dilution 1/100 cDNA. target,
                                           normalized endogenous reference (ucp2 ucp4) relative calibrator (rpl13a
                                           hprt) calculated using 2−ΔΔCT method statistical significance determined
                                           using paired t tests.




                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                              Page 6


                               Statistics
                                            Statistics nematode data performed using way ANOVA, correction                                             multiple testing Tukey’s Multiple Comparison Test. Data expressed mean±SEM
NIH-PA Author Manuscript




                                            > 60–200 nematodes group depending experiments performed                                              legends figures). Student’s t-tests used striatal cell data. Data expressed                                             mean±SD > 150 cells group. Student’s t-test used gene protein
                                            expression data. experiments repeated times. P < 0.05 considered
                                            significant.

                               Results
                               β-catenin ucp-4 required neuroprotection increased sir-2.1 dosage C.
                               elegans
                                            Nematodes expressing normal (19Q) polyQs touch receptor neurons moderate loss
                                            response touch, nematodes bearing expanded (128Q) polyQ strong
                                            loss response touch (85 ). touch phenotype accompanied axonal swelling
                                             importantly, occurs absence cell death (Parker et al., 2005), providing vivo
                                            model manipulate early phases expanded polyQ neurotoxicity.

                                            previously reported sir-2.1/SIRT1-daf-16/FOXO pathway neuroprotective                                             expanded-polyQ nematodes (Parker et al., 2005). Importantly, showed NIH-PA Author Manuscript




                                            neuroprotective effects sir-2.1 overexpression animals unrelated background
                                            mutations produce dye-filling defects influence lifespan C. elegans (Burnett
                                            et al., 2011), sir-2.1 overexpressor strain used does dye-filling
                                            defects. Recent work C. elegans suggested DAF-16 gain specificity                                             regulation lifespan biological processes, DAF-16 interact different 
                                            factors (Wolff et al., 2006; Landis Murphy, 2010; Yen et al., 2011).                                              investigate regulation neuronal survival sir-2.1/SIRT1-daf-16/FOXO,                                             examined evolutionary conserved FOXO factor BAR-1/β-catenin. BAR-1/β-
                                            catenin directly interacts DAF-16 FOXO3a shown role
                                            oxidative stress signaling (Essers et al., 2005). Loss function (LOF) bar-1 enhanced
                                            loss response touch 128Q nematodes effect detected 19Q nematodes
                                            (Fig. 1A) change detected 128Q transgene expression (Fig. 1C), indicating                                             bar-1 protects neuron dysfunction induced expanded polyQs.

                                             examined putative DAF-16 target gene, ucp-4 expand daf-16 affect
                                            neuronal survival. ucp-4 gene encodes sole mitochondrial uncoupling protein
                                            (UCP) C. elegans (Iser et al., 2005). tested ucp-4 reasons.  UCPs                                             transcriptional targets FOXO suggested bioinformatic survey DAF-16
NIH-PA Author Manuscript




                                            binding sites C. elegans genome (Lee et al., 2003) transcriptome analysis                                             Foxo3a-null mouse neural stem cells (Paik et al., 2009). Second, UCPs thought                                             essential neuron survival neurodegenerative disease pathogenesis (Andrews et al.,
                                            2005a). Deletion ucp-4 resulted enhanced neuronal dysfunction 128Q animals                                             effect 19Q animals (Fig. 1B) change detected 128Q transgene expression
                                            (Fig. 1C), indicating ucp-4 protects neuron dysfunction induced expanded
                                            polyQs.

                                            128Q nematodes, neuronal dysfunction intrisincly connected dosage sir-2.1
                                            (Parker et al., 2005; Burnett et al., 2011). Neuron dysfunction aggravated sir-2.1 LOF
                                            (Parker et al., 2005), effect rescued overexpression wild-type sir-2.1                                             mechanosensory neurons effect vector control, suggesting effect                                             sir-2.1 LOF cell-autonomous (Fig. 1D). aggravation neuron dysfunction LOF                                             bar-1 128Q nematodes (Fig. 1A) cell-autonomous suggested rescue 
                                                J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                              Page 7


                                           effect overexpression wild-type bar-1 mechanosensory neurons effect
                                           vector control (Fig. 1D). contrast aggravation sir-2.1 LOF, increased
                                           sir-2.1 dosage neuroprotective requires daf-16 (Parker et al., 2005). NIH-PA Author Manuscript




                                           tested DAF-16 factor bar-1 putative DAF-16 target ucp-4                                            required neuroprotective activity sir-2.1. increase touch response induced
                                           sir-2.1 overexpression lost 128Q animals bearing bar-1 ucp-4 LOF
                                           mutation, detrimental effects bar-1 LOF ucp-4 LOF touch response                                            similar 128Q nematodes 128Q nematodes bearing increased sir-2.1 dosage (Fig. 1E).
                                           results indicated neuroprotective effect sir-2.1 addition                                            requiring daf-16 dependent bar-1 ucp-4.

                               ucp-4 promoter regulated DAF-16
                                           Having shown ucp-4 required sir-2.1 regulate expanded polyQ toxicity C.
                                           elegans neurons, tested ucp-4 gene, putative DAF-16 target (Lee et
                                           al., 2003; Paik et al., 2009), directly regulated DAF-16. scanned promoter
                                           ucp-4 identified 3 consensus DAF-16 binding sites 5 kb upstream                                            translation start site (Fig. 2A). isolated worm extracts mix staged
                                           populations wild-type (N2) animals mutant daf-2 IGF1R daf-16/
                                           FOXO  performed Chromatin Immunoprecipitation (ChIP) anti-
                                           DAF-16 antibody test DAF-16 direct binding ucp-4 promoter (Oh et al., 2006;
                                           Mukhopadhyay et al., 2008). statistically-significant difference binding
NIH-PA Author Manuscript




                                           signals binding site 1 3’-region daf-16 mutant animals, signifying DAF-16
                                           independent recruitment (Fig. 2A). contrast, binding signals strongly decreased                                            binding site 2 DAF-16 absent, signifying DAF-16 dependence (Fig. 2A). test
                                           functional role binding site 2, generated C. elegans transgenic strains stably
                                           expressing mCherry control ucp-4 promoter (1768-bp fragment)                                            carried wild-type scrambled DAF-16 binding site 2, crossed strains                                            DAF-16 protein overexpression daf-16 knockout background. Firstly, constructs encoding
                                           UCP-4∷mCherry control ucp-4 promoter stably expressed wild-
                                           type N2 strain strain overexpressing DAF-16∷GFP (translational construct TJ356),                                            intensity mCherry signals quantified late L4 animals pharynx area,                                            area DAF-16 isoforms UCP-4 known expressed (Lee et al., 2001; Lin et
                                           al., 2001) using independent arrays genotype greater 60 animals/array (20–
                                           30 animals independent experiment total 3 independent experiments).
                                           expression mCherry increased (P < 0.005) animals bearing DAF-16
                                           overexpression (mean±SEM: 40±2.7, arbitray unit) compared wild-type (mean±SEM:
                                           57±2.8, arbitray unit)  Fig. 2B). Secondly, mCherry expression required DAF-16
                                           binding site 2 shown loss variation mCherry expression animals bearing
NIH-PA Author Manuscript




                                           daf-16 LOF DAF-16 overexpression ucp-4 promoter carried scrambled
                                           sequence binding site (Fig. 2C).  experiments suggested                                            ucp-4 promoter regulated DAF-16.

                               GSK-3β inhibitors require bar-1, sir-2.1, daf-16 ucp-4 neuroprotection
                                           expand mechanistic basis neuroprotection sir-2.1 connection                                            daf-16 bar-1 activities, sought look regulation β-catenin, protein                                            Wnt signaling pathway primarily targeted degradation direct
                                           phosphorylation GSK-3β kinase. Interestingly, previous studies simple model
                                           shown GSK-3β inhibitors lithium protect expanded polyQs
                                           (Berger et al., 2005; Voisine et al., 2007), suggesting GSK-3β inhibitors useful
                                           HD therapy.  tested sir-2.1, daf-16, bar-1 ucp-4                                            required neuroprotection GSK-3β inhibitors. tested 6-bromoindirubin-3'-
                                           oxime (BIO), selective inhibitor GSK-3β, observed 100-30 µM BIO


                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                             Page 8


                                           significantly reduced neuron dysfunction 128Q animals effect detected 19Q
                                           animals (Fig. 3A) change detected 128Q transgene expression (Fig. 3C). 
                                           neuroprotection BIO lost 128Q nematodes mutant genes
NIH-PA Author Manuscript




                                           including sir-2.1, daf-16, bar-1 ucp-4 (Fig. 3A), indicating genes required                                            BIO activity. BIO reduced axonal swelling (Fig. 3B), reflect increased
                                           neuron health consistent BIO ability reduce loss touch response 128Q
                                           nematodes. tested lithium chloride, drug GSK-3β inhibition properties,
                                           observed neuroprotective effects similar BIO (data shown). BIO
                                           lithium secondary targets GSK-3β, genome-scale functional
                                           RNAi screen indicated gsk-3 inactivation neuroprotective expanded-polyQ
                                           nematodes (Lejeune et al., 2012), suggesting neuroprotective effects BIO                                            lithium involve GSK-3β target.  results suggested                                            neuroprotective properties GSK-3β inhibitors require sir-2.1, daf-16, bar-1 ucp-4,
                                           useful protecting HD neurons dysfunction induced mutant
                                           polyQs.

                               β-catenin, SIRT1 overexpression UCPs modulate survival mouse striatal cells
                                           Having shown sir-2.1, bar-1 ucp-4 modulate neurotoxicity N-terminal htt
                                           fragment nematodes, tested mammalian counterparts effect
                                           length cellular model HD. end, used striatal cells derived htt
                                           knock mice HdhQ111 (Trettel et al., 2000). Mutant htt (109Q/109Q) striatal cells NIH-PA Author Manuscript




                                           higher rate cell death induced serum deprivation compared wild-type (7Q/7Q) cells
                                           (Trettel et al., 2000), providing assay test cell vulnerability mutant htt
                                           expressed endogenous levels (Fig. 4A). test implication htt cell death
                                           induced serum deprivation, subjected cells htt siRNA treatment using                                            previously described siRNA (DiFiglia et al., 2007) corresponding scramble RNA.
                                           Reducing htt levels 109Q/109Q cells strongly decreased cell mortality serum
                                           deprivation, change detected 7Q/7Q cells (Fig. 4B), suggesting significant
                                           percent cell mortality associated mutant htt expression. previously reported
                                           (Gines et al., 2003), mutant htt cells showed increased β-catenin levels (data shown)                                            correspond pro-survival response (Gines et al., 2003). test role β-
                                           catenin striatal cell survival, subjected cells β-catenin siRNA treatment                                             Materials Methods details siRNA experiments). Reducing β-catenin levels
                                           decreased survival 109Q/109Q cells, effect accompanied reduction β-catenin
                                           expression, change htt expression detected (Fig. 4C/D). Consistent                                            effect reducing β-catenin levels, GSK-3β inhibitor BIO enhanced survival                                            109Q/109Q cells (Fig. 4C) detectable change htt expression (Fig. 4D).                                            amelioration cell survival accompanied increased β-catenin expression (Fig. 4D)
NIH-PA Author Manuscript




                                            consistently, lost 109Q/109Q cells incubated BIO β-catenin
                                           siRNA (Fig. 4C).  mouse C. elegans models HD, β-
                                           catenin neuroprotective effects altering dosage detrimental neuronal cell
                                           survival.

                                            explored role SIRTs UCPs mouse striatal cell survival. Reducing
                                           SIRT1 levels showed effect cell survival (Fig. 4E). tested reducing levels
                                           SIRT2 SIRT3, additional sirtuin family members, modulate striatal
                                           cell survival observed effect   lowering sirtuins did affect
                                           neuronal survival. Second, examined neuronal UCPs (UCP2, UCP4). UCP2
                                           siRNAs decreased survival 109Q/109Q cells (Fig. 4E), change htt
                                           expression (Fig. 4F), reduced UCP2 mRNA levels (Fig. 4G). contrast, UCP4
                                           siRNAs increased survival 109Q/109Q cells (Fig. 4E), change htt



                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                               Page 9


                                           expression (Fig. 4F), reduced UCP4 mRNA levels (Fig. 4G), suggesting
                                           evolutionary diversity mouse UCP activity compared sole UCP C. elegans.
NIH-PA Author Manuscript




                                            tested SIRT1 β-catenin cooperate modulation mouse
                                           striatal cell survival sir-2.1/SIRT1 bar-1/β-catenin linked modulate neuron
                                           dysfunction 128Q nematodes. end, overexpressed SIRT1                                            combination β-catenin siRNA. overexpression SIRT1 slightly enhanced                                            survival 109Q/109Q cells subjected serum deprivation change htt levels
                                           (Fig. 5A/B). previously observed, reducing β-catenin levels strongly detrimental                                            109Q/109Q cell survival (Fig. 5A) effect suppressed SIRT1 overexpression,
                                           suggesting raising SIRT1 levels compensate detrimental effect β-catenin
                                           reduction connecting SIRT1 β-catenin pathways.                                            examined individual effects SIRT1 β-catenin mouse striatal cells. Given                                            UCP gene expression regulated FOXO proteins suggested previous studies
                                           (Lee et al., 2003; Paik et al., 2009), tested effects β-catenin reduction                                            SIRT1 overexpression expression levels UCP2 UCP4. mutant htt striatal
                                           cells, reducing β-catenin, aggravates cell death vulnerability, increased mRNA levels
                                           UCP4 (detrimental cell survival) SIRT1 overexpression, slightly
                                           neuroprotective, opposite effect (Fig. 5C). Conversely, reducing β-catenin decreased
                                           mRNA levels UCP2  neuroprotective gene) mutant htt cells,                                            significant effect SIRT1 overexpression (Fig. 5C). results indicated NIH-PA Author Manuscript




                                           SIRT1 β-catenin common effects repression UCP4 levels,                                            differ ability promote UCP2 levels.

                                           Collectively, results consistent documented model                                            FOXO, SIRT1 β-catenin proteins form complex nucleus regulate gene
                                           expression nematodes species (Brunet et al., 2004).  results
                                           highlighted cross-talk β-catenin SIRT1 regulation vulnerability                                            cell death caused mutant htt expression, primarily mediated modulating
                                           levels UCP4, UCP detrimental mutant htt cell survival.

                               Discussion
                                           Sir2/SIRT1 gene target daf-16/FOXO emerged potent protective factors
                                           HD degenerative diseases (Morley et al., 2002; Parker et al., 2005; Cohen et
                                           al., 2006; Kim et al., 2007; Jeong et al., 2011; Jiang et al., 2011). FOXO integrates
                                           numerous signals regulates expression genes (Greer Brunet, 2008;
                                           Landis Murphy, 2010; Yen et al., 2011), essential question FOXO
                                           network protects HD neurons. Does play role early phases mutant htt toxicity
NIH-PA Author Manuscript




                                           neuronal dysfunction vulnerability cell death?

                                           data β-catenin, SIRT1 UCPs participate regulation                                            vulnerability cell death mutant htt striatal cells, consistent protective
                                           effect increased sir-2.1 dosage neuron dysfunction 128Q nematodes, effect
                                           requires daf-16/FOXO (Parker et al., 2005), FOXO cofactor bar-1/β-catenin (Essers
                                           et al., 2005), ucp-4, suggest DAF-16 regulated gene. summarized
                                           Figure 6, results consistent previously-proposed model                                            SIRT1, FOXO β-catenin proteins form complex nucleus regulate gene
                                           expression nematodes species (Tissenbaum Guarente, 2001; Brunet et al.,
                                           2004; Essers et al., 2005; Berdichevsky et al., 2006; Wang et al., 2006). Importantly,
                                           neuroprotective effects SIRT1 activation recently reported mouse models
                                           HD (Jeong et al., 2011; Jiang et al., 2011) FOXO3a acetylation involved                                            SIRT1 protection (Jiang et al., 2011), corroborates C. elegans data. addition,


                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                                           Page 10


                                           neuroprotective effects β-catenin consistently observed expanded-polyQ
                                           nematodes mutant htt striatal cells.  observed differences C.
                                           elegans mouse striatal cells UCP activity. expected evolutionary diversity
NIH-PA Author Manuscript




                                           gene family function widely-observed phenomenon. UCPs profound
                                           effects neurons chronic uncoupling promoting mitochondrial biogenesis                                            elevated ATP levels (Andrews et al., 2005a). enhancement 128Q toxicity                                            nematode ucp-4 mutants suggests ucp-4 normally protect neurons dysfunction
                                           induced expanded polyQ expression.  mouse striatal cells express
                                           mutant htt, UCP4 normally contribute vulnerability, UCP2 protect
                                            consistent neuroprotective effect UCP2 overexpression mouse
                                           models Parkinson’s disease (Andrews et al., 2005b). C. elegans mouse
                                           striatal cell model emphasized neuroprotective effects β-catenin, showed
                                           differences ability account cross-talk Sir2/SIRT1 β-catenin.
                                           Expanded-polyQ nematodes indicated bar-1/β-catenin required sir-2.1/SIRT1
                                           overexpression neuroprotective.  mutant htt striatal cells poorly recapitulated
                                           neuroprotective effects SIRT1 overexpression primarily indicated SIRT1
                                           overexpression compensates detrimental effect β-catenin reduction.

                                           results highlight complexity regulation FOXO factors (Greer                                            Brunet, 2008; Landis Murphy, 2010; Yen et al., 2011), illustrate                                            conclusions role cell survival genes influenced methodological
NIH-PA Author Manuscript




                                           cellular context activity assessed. example, SIRT1 reported                                            deacetylate β-catenin suppress ability activate transcription mammalian cells
                                           (Firestein et al., 2008), appears contrast findings.  study                                            performed human colon cancer cell lines SIRT1-β-catenin homeostasis                                            different compared neurons cells expressing expanded polyQs. addition,                                            studies indicated β-catenin important survival factor normal (Essers et al.,
                                           2005) diseased (Inestrosa Arenas, 2010) cells ability activate                                            TCF FOXO transcription factors.  study neuronal cell death HD                                            suggested abnormal accumulation β-catenin cause neurotoxicity (Godin et al.,
                                           2010). β-catenin neuroprotective early-phases mutant polyQ
                                           cytotoxicity (neuron dysfunction, cell vulnerability), suggests β-catenin homeostasis
                                           activity change pathogenic process HD.

                                           Finally, activation cell survival mechanisms controlled FOXO factors                                            contribute delaying HD pathogenesis. data suggest GSK-3β inhibitors
                                           require FOXO network protecting neurons dysfunction induced                                            expanded polyQs, suggesting GSK-3β potential treatment HD.                                            conclusion, data reveal neuroprotection sirtuin sir-2.1 expanded polyQs
NIH-PA Author Manuscript




                                           requires β-catenin ucp-4 C. elegans, suggesting FOXO interactors modulate                                            early phases mutant polyQ cytotoxicity. findings raise possibility FOXO
                                           interactors role modification pathogenic process HD,                                            addressed future studies.

                               Acknowledgments
                                           thank Cheryl Wellington Michael Hayden constructs encoding htt 128 Glns, Andrew C.
                                           elegans plasmids, Leonard Guarente LG100 strain, Elena Cattaneo cells HdhQ111 mice, Robert E.
                                           Hughes constructs encoding SIRT1 Maryline Mage technical assistance. strains kindly
                                           provided Caenorhabditis Genetics Center, funded National Institutes Health National
                                           Center Research Resources. work supported INSERM, AP-HP, ANR, FRM AFM, Paris, France,
                                           CHDI Foundation Hereditary Disease Foundation, USA. H T. William Randolph Hearst
                                           Young Investigator. project funded endowment William Randolph Hearst
                                           Foundation grant (AG025891) National Institute Aging H T. J P. supported                                            Inserm Young Researcher award.


                                                J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                                 Page 11


                               References
                                           Andrews ZB, Diano S, Horvath TL. Mitochondrial uncoupling proteins CNS: support NIH-PA Author Manuscript




                                              function survival. Nat Rev Neurosci. 2005a; 6:829–840. [PubMed: 16224498]
                                           Andrews ZB, Horvath B, Barnstable CJ, Elsworth J, Yang L, Beal MF, Roth RH, Matthews RT,
                                              Horvath TL. Uncoupling protein-2 critical nigral dopamine cell survival mouse model                                               Parkinson's disease. J Neurosci. 2005b; 25:184–191. [PubMed: 15634780]
                                           Anselmi CV, Malovini  Roncarati R, Novelli V, Villa F, Condorelli G, Bellazzi R, Puca AA.
                                              Association FOXO3A locus extreme longevity southern Italian centenarian study.
                                              Rejuvenation Res. 2009; 12:95–104. [PubMed: 19415983]
                                           Arango M, Holbert S, Zala D, Brouillet E, Pearson J, Regulier E, Thakur AK, Aebischer P, Wetzel R,
                                              Deglon N, Neri C. CA150 expression delays striatal cell death overexpression knock                                               conditions mutant huntingtin neurotoxicity. J Neurosci. 2006; 26:4649–4659. [PubMed:
                                              16641246]
                                           Berdichevsky  Viswanathan M, Horvitz HR, Guarente L. C. elegans SIR-2.1 interacts 14-3-3
                                              proteins activate DAF-16 extend life span. Cell. 2006; 125:1165–1177. [PubMed: 16777605]
                                           Berger  Ttofi EK, Michel CH, Pasco M, Tenant S, Rubinsztein DC, O'Kane CJ. Lithium rescues
                                              toxicity aggregate-prone proteins Drosophila perturbing Wnt pathway. Hum Mol Genet.
                                              2005
                                           Brunet  Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R,
                                              Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg 
                                              Stress-dependent regulation FOXO transcription factors SIRT1 deacetylase. Science.
NIH-PA Author Manuscript




                                              2004; 303:2011–2015. [PubMed: 14976264]
                                           Burnett C, et al. Absence effects Sir2 overexpression lifespan C. elegans Drosophila.
                                              Nature. 2011; 477:482–485. [PubMed: 21938067]
                                           Cohen, E.; Bieschke, J.; Perciavalle, RM.; Kelly, JW.; Dillin,  Science. Vol. 313. New York, NY:
                                              2006. Opposing activities protect age-onset proteotoxicity; p. 1604-1610.
                                           DiFiglia M, Sena-Esteves M, Chase K, Sapp E, Pfister E, Sass M, Yoder J, Reeves P, Pandey RK,
                                                Rajeev KG, Manoharan M, Sah DW, Zamore PD, Aronin N. Therapeutic silencing mutant
                                                huntingtin siRNA attenuates striatal cortical neuropathology behavioral deficits.
                                                Proceedings National Academy Sciences United States America. 2007;
                                                104:17204–17209. [PubMed: 17940007]
                                           Essers, MA.; Vries-Smits, LM.; Barker, N.; Polderman, PE.; Burgering, BM.; Korswagen, HC.
                                                Science. Vol. 308. New York, NY: 2005. Functional interaction beta-catenin FOXO
                                                oxidative stress signaling; p. 1181-1184.
                                           Firestein R, Blander G, Michan S, Oberdoerffer P, Ogino S, Campbell J, Bhimavarapu  Luikenhuis
                                                S, Cabo R, Fuchs C, Hahn WC, Guarente LP, Sinclair DA. SIRT1 deacetylase suppresses
                                                intestinal tumorigenesis colon cancer growth. PLoS  2008; 3:e2020. [PubMed: 18414679]
                                           Gayan J, Brocklebank D, Andresen JM, Alkorta-Aranburu G, Zameel Cader M, Roberts SA, Cherny
                                                SS, Wexler NS, Cardon LR, Housman  Genomewide linkage scan reveals novel loci
NIH-PA Author Manuscript




                                                modifying age onset Huntington's disease Venezuelan HD kindreds. Genet Epidemiol.
                                                2008; 32:445–453. [PubMed: 18481795]
                                           Ghazi  Henis-Korenblit S, Kenyon C. transcription elongation factor links signals                                                 reproductive lifespan extension Caenorhabditis elegans. PLoS Genet. 2009;
                                                5:e1000639. [PubMed: 19749979]
                                           Giles AC, Rankin CH. Behavioral genetic characterization habituation using Caenorhabditis
                                                elegans. Neurobiol Learn Mem. 2009; 92:139–146. [PubMed: 18771741]
                                           Gines S, Ivanova E, Seong  Saura CA, MacDonald  Enhanced Akt signaling early pro-
                                                survival response reflects N-methyl-D-aspartate receptor activation Huntington's disease
                                                knock striatal cells. J Biol Chem. 2003; 278:50514–50522. [PubMed: 14522959]
                                           Godin JD, Poizat G, Hickey MA, Maschat F, Humbert S. Mutant huntingtin-impaired degradation                                                 beta-catenin causes neurotoxicity Huntington's disease. EMBO journal. 2010; 29:2433–
                                                2445. [PubMed: 20531388]




                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                                   Page 12


                                           Greer EL, Brunet  Signaling networks aging. J Cell Sci. 2008; 121:407–412. [PubMed:
                                                18256383]
                                           Henderson ST, Johnson TE. daf-16 integrates developmental environmental inputs mediate
NIH-PA Author Manuscript




                                                aging nematode Caenorhabditis elegans. Curr Biol. 2001; 11:1975–1980. [PubMed:
                                                11747825]
                                           Holbert S, Denghien  Kiechle T, Rosenblatt  Wellington C, Hayden MR, Margolis RL, Ross CA,
                                                Dausset J, Ferrante RJ, Neri C. Gln-Ala repeat transcriptional activator CA150 interacts                                                 huntingtin: Neuropathologic genetic evidence role Huntington's disease pathogenesis.
                                                Proceedings National Academy Sciences United States America. 2001;
                                                98:1811–1816. [PubMed: 11172033]
                                           Inestrosa NC, Arenas E. Emerging roles Wnts adult nervous  Nat Rev Neurosci. 2010;
                                                11:77–86. [PubMed: 20010950]
                                           Iser WB, Kim D, Bachman E, Wolkow C. Examination requirement ucp-4, putative
                                                homolog mammalian uncoupling proteins, stress tolerance longevity C. elegans.
                                                Mech Ageing Dev. 2005; 126:1090–1096. [PubMed: 15893362]
                                           Jeong H, Cohen  Cui L, Supinski  Savas JN, Mazzulli JR, Yates JR 3rd, Bordone L, Guarente L,
                                                Krainc D. Sirt1 mediates neuroprotection mutant huntingtin activation TORC1                                                 CREB transcriptional pathway. Nat Med. 2011; 18:159–165. [PubMed: 22179316]
                                           Jiang M, et al. Neuroprotective role Sirt1 mammalian models Huntington's disease                                                 activation multiple Sirt1 targets. Nat Med. 2011; 18:153–158. [PubMed: 22179319]
                                           Kim D, Nguyen MD, Dobbin MM, Fischer  Sananbenesi F, Rodgers JT, Delalle  Baur JA, Sui G,
NIH-PA Author Manuscript




                                                Armour SM, Puigserver P, Sinclair DA, Tsai LH. SIRT1 deacetylase protects                                                 neurodegeneration models Alzheimer's disease amyotrophic lateral sclerosis.                                                 EMBO journal. 2007; 26:3169–3179. [PubMed: 17581637]
                                           Landis JN, Murphy CT. Integration diverse inputs regulation Caenorhabditis elegans
                                                DAF-16/FOXO. Dev Dyn. 2010; 239:1405–1412. [PubMed: 20140911]
                                           Lee RY, Hench J, Ruvkun G. Regulation C. elegans DAF-16 human ortholog FKHRL1                                                 daf-2 insulin-like signaling pathway. Curr Biol. 2001; 11:1950–1957. [PubMed: 11747821]
                                           Lee SS, Kennedy S, Tolonen AC, Ruvkun G. DAF-16 target genes control C. elegans life-span
                                                metabolism. Science. 2003; 300:644–647. [PubMed: 12690206]
                                           Lejeune FX, Mesrob L, Parmentier F, Bicep C, Vazquez-Manrique RP, Parker JA, Vert JP, Tourette C,
                                                Neri C. Large-scale functional RNAi screen C. elegans identifies genes regulate                                                 dysfunction mutant polyglutamine neurons. BMC Genomics. 2012; 13:91. [PubMed:
                                                22413862]
                                           Li JL, et al. Genome Scan Modifiers Age Onset Huntington Disease: HD MAPS
                                                Study. J Hum Genet. 2003; 73:682–687. [PubMed: 12900792]
                                           Li Y, Wang WJ, Cao H, Lu J, Wu C, Hu FY, Guo J, Zhao L, Yang F, Zhang YX, Li W, Zheng GY,
                                                Cui H, Chen X, Zhu  H, Dong B, Mo X, Zeng Y, Tian XL. Genetic association FOXO1A
                                                FOXO3A longevity trait Han Chinese populations. Hum Mol Genet. 2009; 18:4897–
                                                4904. [PubMed: 19793722]
NIH-PA Author Manuscript




                                           Lin K, Hsin H, Libina N, Kenyon C. Regulation Caenorhabditis elegans longevity protein
                                                DAF-16 insulin/IGF-1 germline signaling. Nat Genet. 2001; 28:139–145. [PubMed:
                                                11381260]
                                           Metzger S, Rong J, Nguyen HP, Cape  Tomiuk J, Soehn  Propping P, Freudenberg-Hua Y,
                                                Freudenberg J, Tong L, Li SH, Li XJ, Riess O. Huntingtin-associated protein-1 modifier                                                 age onset Huntington's disease. Hum Mol Genet. 2008; 17:1137–1146. [PubMed: 18192679]
                                           Morley JF, Brignull HR, Weyers JJ, Morimoto RI. threshold polyglutamine-expansion protein
                                                aggregation cellular toxicity dynamic influenced aging Caenorhabditiselegans.
                                                Proceedings National Academy Sciences United States America. 2002;
                                                99:10417–10422. [PubMed: 12122205]
                                           Mukhopadhyay  Deplancke B, Walhout AJ, Tissenbaum HA. Chromatin immunoprecipitation
                                                (ChIP) coupled detection quantitative real-time PCR study transcription factor binding                                                 DNA Caenorhabditis elegans. Nat Protoc. 2008; 3:698–709. [PubMed: 18388953]




                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                                Page 13


                                           Oh SW, Mukhopadhyay  Dixit BL, Raha T, Green MR, Tissenbaum HA. Identification direct
                                               DAF-16 targets controlling longevity, metabolism diapause chromatin
                                               immunoprecipitation. Nat Genet. 2006; 38:251–257. [PubMed: 16380712]
NIH-PA Author Manuscript




                                           Paik JH, Ding  Narurkar R, Ramkissoon S, Muller F, Kamoun WS, Chae SS, Zheng H, Ying H,
                                               Mahoney J, Hiller D, Jiang S, Protopopov  Wong WH, Chin L, Ligon KL, DePinho RA. FoxOs
                                               cooperatively regulate diverse pathways governing neural stem cell homeostasis. Cell Stem Cell.
                                               2009; 5:540–553. [PubMed: 19896444]
                                           Parker JA, Arango M, Abderrahmane S, Lambert E, Tourette C, Catoire H, Neri C. Resveratrol rescues
                                               mutant polyglutamine cytotoxicity nematode mammalian neurons. Nat Genet. 2005;
                                               37:349–350. [PubMed: 15793589]
                                           Soerensen M, Dato S, Christensen K, McGue M, Stevnsner T, Bohr VA, Christiansen L. Replication
                                               association variation FOXO3A gene human longevity using case-control
                                               longitudinal data. Aging Cell. 2010; 9:1010–1017. [PubMed: 20849522]
                                           Taherzadeh-Fard E, Saft C, Andrich J, Wieczorek S, Arning L. PGC-1alpha modifier onset age                                                Huntington disease. Mol Neurodegener. 2009; 4:10. [PubMed: 19200361]
                                           Tissenbaum HA, Guarente L. Increased dosage sir-2 gene extends lifespan Caenorhabditis
                                               elegans. Nature. 2001; 410:227–230. [PubMed: 11242085]
                                           Trettel F, Rigamonti D, Hilditch-Maguire P, Wheeler VC, Sharp AH, Persichetti F, Cattaneo E,
                                               MacDonald  Dominant phenotypes produced HD mutation STHdh(Q111) striatal
                                               cells. Hum Mol Genet. 2000; 9:2799–2809. [PubMed: 11092756]
                                           Voisine C, Varma H, Walker N, Bates EA, Stockwell BR, Hart AC. Identification potential
NIH-PA Author Manuscript




                                               therapeutic drugs huntington's disease using Caenorhabditis elegans. PLoS  2007; 2:e504.
                                               [PubMed: 17551584]
                                           Walker FO. Huntington's disease. Lancet. 2007; 369:218–228. [PubMed: 17240289]
                                           Wang Y, Oh SW, Deplancke B, Luo J, Walhout AJ, Tissenbaum HA. C. elegans 14-3-3 proteins
                                               regulate life span interact SIR-2.1 DAF-16/FOXO. Mech Ageing Dev. 2006;
                                               127:741–747. [PubMed: 16860373]
                                           Willcox BJ, Donlon TA, Q, Chen R, Grove JS, Yano K, Masaki KH, Willcox DC, Rodriguez B,
                                               Curb JD. FOXO3A genotype strongly associated human longevity. Proceedings                                                National Academy Sciences United States America. 2008; 105:13987–13992.
                                               [PubMed: 18765803]
                                           Wolff S, Ma H, Burch D, Maciel GA, Hunter T, Dillin  SMK-1, essential regulator DAF-16-
                                               mediated longevity. Cell. 2006; 124:1039–1053. [PubMed: 16530049]
                                           Xu EH, Tang Y, Li D, Jia JP. Polymorphism HD UCHL-1 genes Huntington's disease. J Clin
                                               Neurosci. 2009; 16:1473–1477. [PubMed: 19683447]
                                           Yen K, Narasimhan SD, Tissenbaum HA. DAF-16/Forkhead box O transcription factor: paths                                                single Fork(head) road. Antioxid Redox Signal. 2011; 14:623–634. [PubMed: 20673162]
NIH-PA Author Manuscript




                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                        Page 14
NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                           Figure 1.
                                           β-catenin ucp-4 required neuroprotection sir-2.1 128Q nematodes.  bar-1/
                                           #x003B2;-catenin null mutation enhanced touch insensitivity tail 128Q nematodes.
                                           change detected 19Q animals. ***P < 0.001 compared 128Q  B, ucp-4
                                           deletion enhanced 128Q neuronal dysfunction. change detected 19Q animals.
                                           ***P < 0.001 compared 128Q  C, 128Q transgene expression unchanged                                            protein mRNA levels 128Q nematodes bearing bar-1 ucp-4 LOF. D, Aggravation
                                           neuron dysfunction sir-2.1 LOF (sir-2.1(ok434)) suppressed animals
                                           specifically overexpressing wild-type SIR-2.1 touch receptors neurons control


                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                       Page 15


                                           promoter mec-3 gene effect detected animals overexpressing                                            vector (ID1296 ID1297; Table 1). Aggravation neuron dysfunction bar-1 LOF
                                           (bar-1(ga80)) suppressed animals specifically overexpressing wild-type BAR-1 NIH-PA Author Manuscript




                                           touch receptors neurons control promoter mec-3 gene effect
                                           detected detected animals overexpressing vector (ID1316 ID1317; Table
                                           1). Shown data compiled independent extrachromosomal arrays genotype.
                                           ***P < 0.001 versus vector. n.s.: significant. E, Neuroprotection increased
                                           Sir2 dosage (sir-2.1(O/E)) 128Q toxicity lost animals mutant bar-1                                            ucp-4. *P < 0.001 versus 128Q. **P < 0.001 versus sir-2.1(O/E)  Data panels  B
                                           E means±SEM greater 200 animals/genotype (50–60 animals                                            independent experiment total 4 independent experiments). Data touch
                                           tests strains expressing extrachromosomal arrays (panel D) means±SEM greater
                                           60 animals/array (20–30 animals independent experiment total 3
                                           independent experiments).
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                        Page 16
NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                           Figure 2.
                                           UCP-4 promoter regulated DAF-16.  DAF-16 binds UCP-4 promoter.                                            5’ region UCP-4 3 consensus DAF-16 binding sites (upper panel; 2 sites                                            shown; Binding site 1 closely located consensus sites) separated 3.7 kb.
                                           binding sites located 894 bp upstream ATG (binding site 2)                                            located 4.655 4.964 kb upstream ATG. sites closely
                                           situated, primers designed site 4.655 kb (binding site 1). Primers                                            designed region 654 bp downstream stop codon control site 3’-region.
                                           Chromatin immunoprecipitation (lower panel) using anti-DAF-16 antibody (lower panel)


                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                         Page 17


                                           using N2, daf-2(e1370), daf-16(mgDf50) daf-16(mgDf50);daf-2(e1370). binding
                                           normalized N2, effects P < 0.01 considered significant. *P
                                           < 0.005 compared N2. B, Representative images DAF-16 overexpression increase
NIH-PA Author Manuscript




                                           activity UCP-4 promoter (1768 bp) late L4 C. elegans nematodes inferred
                                           quantifying intensity mCherry signals pharynx  Results). C,                                            effects DAF-16 activity ucp-4 promoter requires binding site 2. Constructs
                                           encoding mCherry control ucp-4 promoter (1768 bp), carried wild-
                                           type (ucp-4p WT) scrambled (ucp-4p SCR) binding site 2, stably expressed N2,
                                           daf-16(mu86) TJ356 strain mCherry signals quantified indicated B. Data                                            mean±SEM compiled independent arrays (SL1, SL2) genotype greater
                                           60 animals/array (20–30 animals independent experiment total 3
                                           independent experiments).
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                        Page 18
NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                           Figure 3.
                                           GSK-3β inhibitor BIO neuroprotective FOXO signaling 128Q nematodes. 
                                           Neuron dysfunction 128Q nematodes higher compared 19Q nematodes,                                            85  128Q animals having defective response touch  Parker et al., 2005). BIO
                                           strongly rescues expanded polyQ neurotoxicity 100-33.3 µM (*P < 0.001 **P < 0.01
                                           versus DMSO controls) effect 19Q animals. BIO rescuing activity lost                                            mutants daf-16, sir-2.1, bar-1 ucp-4. Dilution factor 3x. Percent rescue                                            calculated percentages touch response ((test – control)/(100 – control) * 100).
                                           Data means±SEM greater 200 animals/point genotypes (50–60 animals


                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                    Page 19


                                           independent experiment total 4 independent experiments).                                            percentages touch response (means±SEM) 52±3  19Q animals treated                                            vehicle, 23±2  128Q animals treated vehicle, 46±3  128Q animals treated NIH-PA Author Manuscript




                                           100 µM BIO 34.6±4  128Q animals treated 33.3 µM BIO. B, BIO reduced
                                           axonal swelling PLM cells 128Q animals (*P < 0.002 versus DMSO controls). Data                                            means±SEM greater 100 animals/treatment (25–30 animals independent
                                           experiment total 4 independent experiments). C, BIO treatment (50 µM,
                                           100µM) does modify transgene expression 128Q nematodes. n.s., significant.
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                              J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                        Page 20
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                           Figure 4.
                                           β-catenin UCP2/UCP4 modulate survival mutant htt striatal cells HdhQ111
                                           mice. assays, cells subjected serum deprivation.  Representative graph
                                           showing 109Q/109Q cells susceptible cell death compared 7Q/7Q cells
                                           (N (Number independent experiments) = 3 SD; *P < 0.01 compared 7Q/7Q). B,
                                           Effects reducing htt levels. Htt siRNA reduced 109Q/109Q cell mortality (N = 3 SD;
                                           **P < 0.001 versus untreated). Scramble RNA showed effect. ns: significant.                                            following panels, data normalized variability striatal cell survival NIH-PA Author Manuscript




                                           serum deprivation experiments. C, Effects reducing β-catenin levels BIO
                                           (0.5 µM) treatment. Left panel: β-catenin siRNA enhanced 109Q/109Q cell mortality (N = 3
                                           SD; *P < 0.01 versus untreated). Scramble RNA showed effect. BIO treament
                                           reduced cell mortality (N = 3 SD; **P < 0.05 versus DMSO controls). β-catenin
                                           siRNA BIO combined, change cell mortality detected compared cells
                                           treated scramble RNA DMSO (N = 3 SD). Right panel: β-catenin siRNA                                            BIO showed effect 7Q/7Q cells. D, Mutant htt expression unchanged treatment
                                           BIO β-catenin siRNA. β-catenin levels increased BIO (N = 3, P < 0.02)                                            reduced β-catenin siRNA (n = 3, P < 0.05). Scramble RNA effect. E, Effects                                            reducing SIRT1, UCP2 UCP4 (N = 4 SD). UCP2 siRNA enhanced 109Q/109Q cell
                                           mortality (*P < 0.01 versus untreated) effect detected 7Q/7Q cells. UCP4 siRNA
                                           reduced 109Q/109Q cell mortality (*P < 0.01 versus untreated) effect detected                                            7Q/7Q cells. Scramble RNAs effect. F, Mutant htt expression unchanged                                            siRNAs SIRT1, UCP2 UCP4. Shown representative western blots. Scramble


                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                       Page 21


                                           RNAs showed effect. G, Left panel representative western blot image showing                                            109Q/109Q cells lower SIRT1 levels SIRT1 siRNA treatment (N = 3; P < 0.05).
                                           Quantitative RT-PCR experiments indicated UCP2 UCP4 siRNA decreased mRNA
NIH-PA Author Manuscript




                                           levels UCP2 UCP4, respectively (N = 5 SD; P < 0.05). effect UCP2/4
                                           siRNAs target protein expression evaluated antisera repeatedly
                                           unable detect protein western blot experiments, scramble RNAs showed                                            effect. panels, N indicates number independent experiments performed.
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                          Page 22
NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                           Figure 5.
                                           Effects β-catenin SIRT1 mutant htt striatal cells HdhQ111 mice.  Mutant
                                           htt cells showed increased susceptibility cell death induced serum deprivation (***P <
                                           0.001 compared 7Q/7Q). SIRT1 overexpression slightly enhanced survival 109Q/
                                           109Q striatal cells effects 7Q/7Q cells (**P < 0.01 compared untreated 109Q/
                                           109Q). Reducing β-catenin enhanced mortality 109Q/109Q striatal cells                                            effects 7Q/7Q cells (***P < 0.001 compared untreated 109Q/109Q). SIRT1
                                           overexpression combined β-catenin reduction 109Q/109Q striatal cells,                                            detrimental effect reducing β-catenin compensated SIRT1 overexpression (N
                                           (number experiments performed) = 3 SD; ***P < 0.001 compared β-catenin
                                           reduction). n.s., significant. B, Representative western blot showing striatal cells


                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                          Page 23


                                           transfected SIRT1 construct  active variant lacking internal segment N-
                                           terminus) increased SIRT1 levels. n , applicable. C, Effects reducing β-catenin
                                           overexpressing SIRT1 expression levels UCP4 UCP2. Upper panel: NIH-PA Author Manuscript




                                           expression UCP4 gene upregulated β-catenin siRNA dowregulated                                            SIRT1 overexpression (O/E) 109Q/109Q cells (N = 4 SD; *P < 0.05). effect                                            detected 7Q/7Q cells. Lower panel: expression UCP2 gene downregulated
                                           β-catenin siRNA effect SIRT1 overexpression (O/E) 109Q/109Q cells (N =
                                           4 SD; *P < 0.05). effect detected 7Q/7Q cells. ns: significant. Scramble
                                           RNA (β-catenin) showed effect UCP2/UCP4 gene expression levels.
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                        Page 24
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                           Figure 6.
                                           Working model role bar-1/β-catenin, daf-16/FOXO sir-2.1/SIRT1 NIH-PA Author Manuscript




                                           regulation mutant polyglutamine neuron homeostasis. effects observed C. elegans
                                           mouse striatal cells, models early-cytotoxicity/cell-vulnerability induced                                            mutant htt, summarized context prior knowledge binding BAR-1/β-
                                           catenin DAF-16/FOXO (Essers et al., 2005) role GSK-3/β-catenin SIRT1                                            modulation FOXO activity nucleus ability regulate gene expression
                                           (Greer Brunet, 2008; Landis Murphy, 2010; Yen et al., 2011). Genes required                                            neuroprotection sir-2.1 C. elegans previously reported (Parker et al., 2005)                                            indicated underligned. Bold indicates gene activity mouse striatal cells                                            suggested ability SIRT1 overexpression compensate detrimental effect                                            reducing β-catenin cell survival, effects UCP2 expression levels.




                                               J Neurosci. Author manuscript; available PMC 2013 September 23.
                            Parker et al.                                                                                                                 Page 25




                                                                                            Table 1
                           Names genotypes C. elegans strains used study.
NIH-PA Author Manuscript




                                      Genotypea                                                                           Origin

                            Bristol N2     Standard wild type                                                                  CGCb
                            TJ356          zIs356[pdaf-16∷daf-16-gfp; rol-6]IV                                                 CGC
                            CB1370         daf-2(e1370)III                                                                     CGC
                            GR1307         daf-16(mgDf50                                                                     CGC
                            HT1890         daf-16(mgDf50 daf-2(e1370)III                                                     CGC
                            CF1038         daf-16(mu86                                                                       CGC
                            EW15           bar-1(ga80)X                                                                        CGC
                            CY121          ucp-4(ok195)V                                                                       CGC
                            LG100          geIn3[sir-2.1; rol-6]; dyf-(?)                                                      L. Guarente
                                                                                                                               (MIT, MA)

                            ID1280c        geIn3[sir-2.1; rol-6]                                                               study

                            ID245          igIs245[mec-3p∷htt57-19Q∷CFP; lin-15(+); mec-7p∷YFP]                                Parker et al., 2005
                            ID1            igIs1[mec-3p∷htt57-128Q∷CFP; lin-15(+); mec-7p∷YFP]                                 Parker et al., 2005
                                           igIs245[mec-3p∷htt57-19Q∷CFP; lin-15(+); mec-7p∷YFP]; bar-1(ga80)X
NIH-PA Author Manuscript




                            ID191                                                                                              study
                            ID1281         igIs1[mec-3p∷htt57-128Q∷CFP; lin-15(+); mec-7p∷YFP]; bar-1(ga80)X                   study
                            ID192          igIs245[mec-3p∷htt57-19Q∷CFP; lin-15(+); mec-7p∷YFP]; ucp-4(ok195)V                 study
                            ID1282         igIs1[mec-3p∷htt57-128Q∷CFP; lin-15(+); mec-7p∷YFP]; ucp-4(ok195)V                  study
                            ID1283         igIs245[mec-3p∷htt57-19Q∷CFP; lin-15(+); mec-7p∷YFP]; sir-2.1(ok434)X               study
                            ID1285         igIs1[mec-3p∷htt57-128Q∷CFP; lin-15(+); mec-7p∷YFP]; sir-2.1(ok434)X                study
                            ID1286         igIs1[mec-3p∷htt57-128Q∷CFP; lin-15(+); mec-7p∷YFP]; daf-16(mgDf50                study
                            ID1287         igIs1[mec-3p∷htt57-128Q∷CFP; lin-15(+); mec-7p∷YFP]; geIn3[sir-2.1; rol-6]          study
                            ID1288         igIs1[mec-3p∷htt57-128Q∷CFP; lin-15(+); mec-7p∷YFP]; geIn3[sir-2.1; rol-6]; bar-    study
                                           1(ga80)X
                            ID1289         igIs1[mec-3p∷htt57-128Q∷CFP; lin-15(+); mec-7p∷YFP]; geIn3[sir-2.1; rol-6]; ucp-    study
                                           4(ok195)V
                            ID1290         igIs245[mec-3p∷htt57-19Q∷CFP; lin-15(+); mec-7p∷YFP]; sir-2.1(ok434)X;              study
                                           igEx500[mec-3p∷sir-2.1-biGFP]
                            ID1291         igIs1[mec-3p∷htt57-19Q∷CFP; lin-15(+); mec-7p∷YFP]; sir-2.1(ok434)X;                study
                                           igEx501[mec-3p∷sir-2.1-biGFP]
                            ID1292         igIs1[mec-3p∷htt57-128Q∷CFP; lin-15(+); mec-7p∷YFP]; sir-2.1(ok434)X;               study
                                           igEx502[mec-3p∷sir-2.1-biGFP]
NIH-PA Author Manuscript




                            ID1293         igIs1[mec-3p∷htt57-128Q∷CFP; lin-15(+); mec-7p∷YFP]; sir-2.1(ok434)X;               study
                                           igEx503[mec-3p∷sir-2.1-biGFP]
                            ID1296         igIs1[mec-3p∷htt57-128Q∷CFP; lin-15(+); mec-7p∷YFP]; sir-2.1(ok434)X;               study
                                           igEx506[mec-3p∷GFP]
                            ID1297         igIs1[mec-3p∷htt57-128Q∷CFP; lin-15(+); mec-7p∷YFP]; sir-2.1(ok434)X;               study
                                           igEx507[mec-3p∷GFP]
                            ID1298         igEx508[ucp-4p∷ucp-4∷mCherry; myo-2p∷GFP]                                           study
                            ID1299         igEx509[ucp-4p∷ucp-4∷mCherry; myo-2p∷GFP]                                           study
                            ID1300         igEx510[ucp-4p∷ucp-4∷mCherry; myo-2p∷GFP]; z